<!DOCTYPE html>
<html>

{{>head}}

<body class="js-body date-selector-page">
  {{>header}}
  <main class="main js-main">
    <aside class="aside">
      <div class="aside__container">
        <h2>Bringing<br>Outcomes<br>to Life</h2>

        <div class="aside__avatar">
          <img src="./assets/images/maintenance-patient-avatar.png" alt="">
        </div>

        <div class="aside__footer">
          <div class="aside__logo">
            <a href="index.html">
              <img src="./assets/images/rev-logo.png" alt="">
            </a>
          </div>
        </div>
      </div>
    </aside>
    <section class="content">
      {{>navigation
        start-date="true"
      }}
      <div class="content__container">
        {{>date-selector}}
      </div>
      <footer class="footer">
        <div class="footer__container">
          <div class="footer__content">
            <small>auto-HSCT, autologous hematopoietic stem cell transplantation.
              <br><br>
              <div class="show-on-study-data-page">
                <strong>Reference: 1.</strong> REVLIMID [package insert]. Summit, NJ: Celgene Corp.
                <br><br>
              </div>
              REVLIMID<sup>®</sup> and REVLIMID REMS<sup>®</sup> is a registered trademark of Celgene Corporation, a
              Bristol-Myers Squibb Company.
              <br>Access Support<sup>®</sup> and the related logo are registered trademarks of Bristol-Myers Squibb
              Company.
              <br>©2021 Bristol-Myers Squibb Company. 10/21 US-REV-20-0400
            </small>
          </div>
        </div>
      </footer>
    </section>
  </main>
  {{>tray
    variant='revpat'
    thirdTab='Medication Guide'
    secondTab='Prescribing Information'
  }}
  {{>modal
    id='starting-dose'
    pdfUrl='../../../assets/images/Patient-Support.pdf'
    modalColor='#dbebf4'
  }}
  {{>footlibs}}
  {{>error-overlay}}
</body>

</html>